Target- |
MechanismImmunologic cytotoxicity [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Prospective and randomized controlled study on the clinical effect of gasless transoral approach and traditional open approach in lateral cervical lymph node dissection of thyroid cancer
A prospective, randomized controlled study on the clinical effect of gasless transoral approach and traditional open approach in the treatment of thyroid cancer
/ Not yet recruitingPhase 2IIT Neoadjuvant Chemotherapy Plus Camrelizumab (NACI Therapy) for Fertility Preservation in FIGO Stage IB1 Cervical Cancer
This multicenter, prospective clinical trial is designed to enroll PD-L1 expression-positive patients with stage IB1 cervical cancer who desire fertility preservation to undergo neoadjuvant chemotherapy in combination with a PD-1 inhibitor to evaluate the rate of complete pathologic remission, treatment-related adverse events, pregnancy rate, miscarriage rate, preterm birth rate, live birth rate, PFS and OS.
100 Clinical Results associated with Anhui Shackle Hospital Co., Ltd.
0 Patents (Medical) associated with Anhui Shackle Hospital Co., Ltd.
100 Deals associated with Anhui Shackle Hospital Co., Ltd.
100 Translational Medicine associated with Anhui Shackle Hospital Co., Ltd.